Clinical trials in Opole – page 5

140 clinical trials in Opole, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PolandBadaniaKliniczne.pl

Opole at a glance

140

clinical trials

Research sites2

Quick filters

140 trials in Opole

Open in trial search

Breast cancer+1

Recruiting

Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

Registered drugNo placebo

Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Coronary artery disease+1

Recruiting

Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

Registered drugNo placebo

Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Triple negative breast cancer

Recruiting

Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

Registered drugNo placebo

Study of sacituzumab tirumotecan, pembrolizumab and chemotherapy combination for early-stage triple-negative breast cancer or hormone receptor-low positive/HER2-negative breast cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Transitional cell cancer of the renal pelvis and ureter

Recruiting

Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer

InvestigationalNo placebo

Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Mitomycin
Sponsor:Urogen Pharma Ltd.

Contact Research Centre

Colitis ulcerative

Recruiting

Study of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis

Investigational

Study of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:RO7837195
Sponsor:Genentech Inc.

Contact Research Centre

Chronic lymphocytic leukaemia refractory+13

Recruiting

Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

Registered drugNo placebo

Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:BGB-16673
Sponsor:BeOne Medicines AG

Contact Research Centre

Cardiac failure chronic+1

Recruiting

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo

Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Ferric Derisomaltose
Sponsor:Pharmacosmos A/S

Contact Research Centre

Heart failure with reduced ejection fraction

Recruiting

Study of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability

Investigational

Study of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Omecamtiv mecarbil
Sponsor:Cytokinetics Inc.

Contact Research Centre

Hypertension

Recruiting

Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

Registered drug

Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Amlodipine
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Colorectal cancer

Recruiting

Study Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations

Registered drugNo placebo

Study Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Amivantamab
Sponsor:Janssen Cilag International

Contact Research Centre

Hormone-refractory prostate cancer+1

Recruiting

Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Registered drug

Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Enzalutamide
Sponsor:Pfizer Inc.

Contact Research Centre

Cardiac failure

Recruiting

Study on Sacubitril and Valsartan to Prevent Heart Damage in Breast Cancer Patients Undergoing Treatment

Registered drug

Study on Sacubitril and Valsartan to Prevent Heart Damage in Breast Cancer Patients Undergoing Treatment

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Sacubitril
Sponsor:Agencja Badań Medycznych

Contact Research Centre

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Opole

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on heart failure treatments, including investigations of medications like sacubitril/valsartan for various cardiac conditions. Research encompasses both acute and chronic heart conditions.

Heart Failure Management
Cardiogenic Shock Treatment
Post-Infarction Care

Multiple trials exploring treatments for patients with reduced ejection fraction and acute cardiac conditions.

02 Oncology Studies

Comprehensive research into various cancer types, with particular focus on breast cancer and prostate cancer treatments. Studies evaluate novel therapeutic approaches and drug combinations.

Metastatic Cancer Treatments
Targeted Therapies
Colorectal Cancer Research

Investigations include both early-stage and advanced cancer treatments using innovative therapeutic agents.

03 Immunology and Inflammation

Studies examining treatments for autoimmune conditions and inflammatory disorders, including research on novel therapies for psoriatic arthritis and urticaria.

Arthritis Management
Inflammatory Bowel Disease
Immune System Disorders

Clinical investigations focus on improving patient outcomes through targeted immunological interventions.

Back to Poland All countries